GlassScriptPhysician profile
Aimee C Popp
NPI 1336270875
$314.28
in general payments reported to CMS, 2019-2025
8 companies · $47.45 in 2025
The $47.45 reported for 2025 was less than what a typical Anatomic Pathology & Clinical Pathology provider received nationally (typical 2025 total: $50.59).
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.32 · 2020: $35.35 · 2023: $107 · 2024: $49.88 · 2025: $47.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $204.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $107.28 | 2023 | Tukysa |
| Daiichi Sankyo INC. | $49.88 | 2024 | Enhertu |
| Hologic Sales and Service, LLC | $47.45 | 2025 | Thinprep 2000 Processor, Trident Specimen Radiography System |
| Astrazeneca Pharmaceuticals LP | $35.42 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.20 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $16.67 | 2019 | |
| Eisai INC. | $14.39 | 2019 | |
| Roche Diagnostics Corporation | $13.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimee Popp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.